U.S. Markets close in 2 hrs 52 mins

FDA panel says Karyopharm's cancer drug shows 'significant toxicity'

Allison DeAngelis
FDA panel says Karyopharm's cancer drug shows 'significant toxicity'

The company's path forward is uncertain after FDA officials wrote in an advisory committee briefing document Friday that Karyopharm's drug was linked to "significant toxicity" and potentially lowered cancer patients' survival rates.